COMBINED METFORMIN-SULFONYLUREA TREATMENT OF PATIENTS WITH NONINSULIN-DEPENDENT DIABETES IN FAIR TO POOR GLYCEMIC CONTROL

被引:84
作者
REAVEN, GM
JOHNSTON, P
HOLLENBECK, CB
SKOWRONSKI, R
ZHANG, JC
GOLDFINE, ID
CHEN, YDI
机构
[1] DEPT VET AFFAIRS MED CTR, CTR GERIATR RES EDUC & CLIN, PALO ALTO, CA 94304 USA
[2] STANFORD UNIV, MED CTR, SCH MED, DEPT MED, STANFORD, CA 94305 USA
关键词
D O I
10.1210/jc.74.5.1020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of metformin treatment was studied in 13 patients with noninsulin-dependent diabetes mellitus (NIDDM), whose fasting plasma glucose concentration was greater than 10 mmol/L with maximal sulfonylurea doses. Patients were studied before and 3 months after receiving 2.5 g/day metformin. The fasting plasma glucose concentration (12.4 +/- 0.8 vs. 8.8 +/- 0.7 mmol/L), mean hourly postprandial plasma glucose concentration from 0800-1600 h (14.0 +/- 1 vs. 9.4 +/- 0.9 mmol/L), and glycosylated hemoglobin level (12.3 +/- 0.6% vs. 9.0 +/- 0.6%) were all significantly (P < 0.005-0.001) lower after the administration of metformin. The improvement in glycemic control was associated with a 24% increase (P < 0.05) in insulin-stimulated glucose uptake during glucose clamp studies and a 16% decrease in basal hepatic glucose production (P < 0.05). Mean hourly concentrations of plasma insulin (411 +/- 73 vs. 364 +/- 73 pmol/L) and FFA concentrations (440 +/- 31 vs. 390 +/- 40-mu-mol/L) were also lower after 3 months of metformin treatment. However, neither insulin binding nor insulin internalization by isolated monocytes changed in response to metformin. Finally, plasma triglyceride, very low density lipoprotein triglyceride, and very low density lipoprotein cholesterol were significantly decreased (P < 0.01-0.001), and high density lipoprotein cholesterol was significantly increased (P < 0.001) after metformin treatment. Thus, the addition of metformin to sulfonylurea-treated patients with NIDDM not in good glycemic control significantly lowered fasting and postprandial plasma glucose concentrations, presumably due to the combination of enhanced glucose uptake and decreased hepatic glucose production. Since the dyslipidemia present in these patients also improved, the results suggest that metformin may be of significant clinical utility in patients with NIDDM not well controlled with sulfonylurea compounds.
引用
收藏
页码:1020 / 1026
页数:7
相关论文
共 42 条
[1]  
ABRAHAM EC, 1983, J LAB CLIN MED, V102, P187
[2]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[3]   DISTURBANCE OF INTESTINAL ABSORPTION FOLLOWING METFORMIN THERAPY (OBSERVATIONS ON MODE OF ACTION OF BIGUANIDES) [J].
BERCHTOL.P ;
BOLLI, P ;
ARBENZ, U ;
KEISER, G .
DIABETOLOGIA, 1969, 5 (06) :405-&
[4]   EFFECT OF TIME ON MEASUREMENT OF HEPATIC GLUCOSE-PRODUCTION [J].
CHEN, YDI ;
SWISLOCKI, ALM ;
JENG, CY ;
JUANG, JH ;
REAVEN, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (05) :1084-1088
[5]   QUANTITATION OF INSULIN-STIMULATED GLUCOSE DISPOSAL IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
DONNER, CC ;
FRAZE, E ;
CHEN, YDI ;
REAVEN, GM .
DIABETES, 1985, 34 (09) :831-835
[6]   RELATIONSHIP OF PLASMA-INSULIN LEVELS TO THE INCIDENCE OF MYOCARDIAL-INFARCTION AND CORONARY HEART-DISEASE MORTALITY IN A MIDDLE-AGED POPULATION [J].
DUCIMETIERE, P ;
ESCHWEGE, E ;
PAPOZ, L ;
RICHARD, JL ;
CLAUDE, JR ;
ROSSELIN, G .
DIABETOLOGIA, 1980, 19 (03) :205-210
[7]  
FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133
[8]   LIPID DISORDERS IN DIABETES [J].
GOLDBERG, RB .
DIABETES CARE, 1981, 4 (05) :561-572
[9]   ASSESSMENT OF INSULIN RESISTANCE WITH THE INSULIN SUPPRESSION TEST AND THE EUGLYCEMIC CLAMP [J].
GREENFIELD, MS ;
DOBERNE, L ;
KRAEMER, F ;
TOBEY, T ;
REAVEN, G .
DIABETES, 1981, 30 (05) :387-392
[10]  
GREENFIELD MS, 1982, ARCH INTERN MED, V142, P1498, DOI 10.1001/archinte.142.8.1498